NHSX Adoption Fund awarded projects to improve digital pathways in England

15

Nov 2021

In November 2021, NHSX announced projects to improve digital pathways awarded for funding from the newly created Adoption Fund. The Adoption Fund will support innovations that have some evidence base in the NHS and can address elective recovery, are compliant with DTAC (Digital Technology Assessment Criteria), are not being funded elsewhere by the NHS, and have the potential for rapid, wide rollout across the NHS. Funding opportunities will support Integrated Care Systems (ICSs) with initiatives to test out digital pathways across various specialty areas:

  • Gastroenterology pathways with up to £200,000 funding available per ICS;
  • Musculoskeletal pathways with up to £200,000 funding available per ICS;
  • Cardiology and cardiac surgery networks with up to £750,000 funding available per cardiac network;
  • Perioperative pathways with up to £500,000 funding available per ICS;
  • Initiatives to support digital inclusion with up to £20,000 per ICS.

The applications were submitted by ICSs to NHSX in August - September 2021. A total of 35 applications were successful and will share funding of £6.5 million.

Eight applications were awarded in the gastroenterology pathway, including the following:

  • IBDoc: Gastro remote care & monitoring. A pilot project for home monitoring of inflammatory bowel disease (IBD) patients using IBDoc, a diagnostic device to determine fecal calprotectin levels in stool samples;
  • Home fecal calprotectin testing pilot in an area of high social deprivation. Pilot project with the use of home fecal calprotectin, in conjunction with DrDoctor tool, within three different groups of IBD patients;
  • Automated endoscopy bowel prep pre-assessment and patient education (Remcare app);
  • Integrating e-Health into the IBD patient pathway using virtual monitoring and fecal calprotectin home testing; Patients will be offered a virtual review via the My IBD Care app, with three monthly calprotectin testing using the CalproSmart home test kits. A smaller group will also trial the feasibility of the Thriva at-home blood testing;
  • Supported self-management and remote monitoring of IBD patients within Herefordshire and Worcestershire. A project to implement the use of the My IBD Care app alongside the CalproSmart at-home fecal calprotectin;

Nine applications were awarded in the musculoskeletal pathway, including the following:

  • Empowering self-management through online education for MSK conditions (Harrogate Health Hub);
  • Web-based exercise prescription to support self-management (Physitrack);
  • Using decision support tools to self-manage low back pain (SelfBack and STarTBack platforms);
  • Going paperless to support patients to self-manage MSK conditions (MyRecovery);
  • Video-based exercise rehabilitation and physiotherapy-led group exercise classes (Rehab Me app);
  • Integrating voluntary, community, and prescribing social resources into digital self-management for common musculoskeletal conditions (GetUBetter platform).

Two applications were awarded in the cardiology and cardiac surgery area:

  • London Cardiac Networks seeks funding for remote monitoring technology and change management resources to implement remote monitoring pathways in elective cardiac surgery and cardiac lists (TAVI, PCI, ablation) in eight London sites. Procured digital solutions will enhance pre and postoperative pathways through digital investigation and virtual clinical tools;
  • Cheshire and Merseyside Cardiac Network has a long track record in delivering enhanced clinical pathways through scaled-up adoption of telehealth. The intention is to expand the use of Docobo, a digital platform already identified by the ICS with a telehealth hub and infrastructure already in place. Docobo’s effectiveness as a telehealth solution has already been established; hence the pilot can focus on the benefits its use brings to the pathway.

Six applications were awarded in the perioperative pathway, and ten projects were awarded as Digital Health Inequality Pioneers (DiHiP).

See the full details here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).

The latest related news

24

Nov 2021

In October 2021, the Scottish Health Technology Group released two Innovative Medical Technology Overviews for e-health technologies. The topics were asynchronous digital dermatology appointment service (DDAS) and the Dxcover™ Brain Cancer Liquid Biopsy. Regarding DDAS, the authors concluded that the Scottish health boards should provide more data to allow for further performance and economic analyses of the DDAS. Regarding Dxcover™, the SHTG concluded that it was cost-effective, but further work to confirm its accuracy, effectiveness, safety, and cost-effectiveness is required.

Read more

23

Nov 2021

In late October 2021, the Treatment Council (Behandlingsråd) published three topics chosen for developing the so-called major analyses (større analyser) in 2022. The selected topics include patient-centered diabetes technology, hand-held focused ultrasound in emergency medicine, and artificial intelligence as decision support for colonoscopy.

Read more

18

Nov 2021

In October 2021, the National Institute for Health and Care Excellence (NICE) published three new Interventional Procedure Guidance (genicular artery embolization for pain from knee osteoarthritis, laparoscopic renal denervation for loin pain hematuria syndrome, percutaneous endovascular forearm arteriovenous fistula creation for hemodialysis access), and one new Medical Technologies Guidance (DyeVert Systems for reducing the risk of acute kidney injury in coronary and peripheral angiography). Also, two new clinical guidelines were published.

Read more

09

Nov 2021

In early October 2021, three more health apps were introduced in the Directory of digital health applications (DiGAs) at the Federal Office for Drugs and Medical Devices (BfArM) and thus became reimbursable. These apps can be prescribed by physicians and psychotherapists and will be reimbursed by health insurers. In total, 23 health apps are now available at the DiGA Directory.

Read more

08

Nov 2021

In late September 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, has published Bulletins 0179 and 0076 with changes to be implemented no later than January 01, 2022. Four new procedure codes related to gynecology, robotic surgery in the pulmonology area, and orthopedics, and four new diagnostic codes were introduced.

Read more